Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Grace Therapeutics, Inc GRCE

Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.


NDAQ:GRCE - Post by User

Comment by postie1on Aug 15, 2020 9:34pm
228 Views
Post# 31413662

RE:RE:acasti

RE:RE:acasti

If they could just have had their act together

"Doctors warn of lasting heart complications

With new evidence and data on the virus emerging almost weekly, health officials now have another warning: the risk of death from coronavirus-related heart damage seems to be far greater than previously thought, the American Heart Association said.

"Basically this virus can put some patients' bodies on fire, including their hearts," Dr. Dara Kass, an emergency physician at Columbia University Medical School told CNN's Bianna Golodryga on Saturday.

Inflammation of the vascular system and injury to the heart occur in 20% to 30% of hospitalized coronavirus patients and contribute to 40% of deaths, the association said Friday.

Dr. Mitchell Elkind, the association's president, said that the cardiac complications of Covid-19 could be "devastating" and linger after recovery.

The AHA said research indicates coronavirus could lead to heart attacks, acute coronary syndromes, stroke, blood pressure abnormalities, clotting issues, heart muscle inflammation and fatal heartbeat irregularities."

 
<< Previous
Bullboard Posts
Next >>